BACKGROUND:Borderline personality disorder (BPD) is a highly prevalent, chronic condition. Because of its very problematic nature BPD is expected to be associated with substantial societal costs, although this has never been comprehensively assessed. OBJECTIVE: Estimate the societal cost of BPD in the Netherlands. STUDY DESIGN: We used a prevalence-based bottom-up approach with a sample of 88 BPD patients who enrolled in a multicenter clinical trial comparing two kinds of outpatient psychotherapy. Costs were assessed by means of a structured interview, covering all healthcare costs, medication, informal care, productivity losses, and out-of-pocket expenses. Only BPD-related costs were included. All costs were expressed in Euros for the year 2000. A bootstrap procedure was performed to determine statistical uncertainty. PATIENTS: All patients had been diagnosed with BPD using DSM-IV criteria. Mean age was 30.5 years and 92% was female. RESULTS: Based on a prevalence of 1.1% and an adult population of 11,990,942, we derived that there were 131,900 BPD patients in the Netherlands. Total bootstrapped yearly cost of illness was 2,222,763,789 euros (1,372,412,403-3,260,248,300 euros), only 22% was healthcare-related. Costs per patient were 16,852 euros. CONCLUSIONS: Although healthcare costs of non-institutionalized Borderline patients might not be disproportionate, total societal costs are substantial.
RCT Entities:
BACKGROUND:Borderline personality disorder (BPD) is a highly prevalent, chronic condition. Because of its very problematic nature BPD is expected to be associated with substantial societal costs, although this has never been comprehensively assessed. OBJECTIVE: Estimate the societal cost of BPD in the Netherlands. STUDY DESIGN: We used a prevalence-based bottom-up approach with a sample of 88 BPD patients who enrolled in a multicenter clinical trial comparing two kinds of outpatient psychotherapy. Costs were assessed by means of a structured interview, covering all healthcare costs, medication, informal care, productivity losses, and out-of-pocket expenses. Only BPD-related costs were included. All costs were expressed in Euros for the year 2000. A bootstrap procedure was performed to determine statistical uncertainty. PATIENTS: All patients had been diagnosed with BPD using DSM-IV criteria. Mean age was 30.5 years and 92% was female. RESULTS: Based on a prevalence of 1.1% and an adult population of 11,990,942, we derived that there were 131,900 BPD patients in the Netherlands. Total bootstrapped yearly cost of illness was 2,222,763,789 euros (1,372,412,403-3,260,248,300 euros), only 22% was healthcare-related. Costs per patient were 16,852 euros. CONCLUSIONS: Although healthcare costs of non-institutionalized Borderline patients might not be disproportionate, total societal costs are substantial.
Authors: Federico Amianto; Andrea Ferrero; Andrea Pierò; Elisabetta Cairo; Giuseppe Rocca; Barbara Simonelli; Simona Fassina; Giovanni Abbate-Daga; Secondo Fassino Journal: BMC Psychiatry Date: 2011-11-21 Impact factor: 3.630
Authors: Marjon Nadort; Arnoud Arntz; Johannes H Smit; Josephine Giesen-Bloo; Merijn Eikelenboom; Philip Spinhoven; Thea van Asselt; Michel Wensing; Richard van Dyck Journal: BMC Psychiatry Date: 2009-10-06 Impact factor: 3.630